Nanomedicine-emerging or re-emerging ethical issues? A discussion of four ethical themes

Medicine, Health Care and Philosophy

Volumn 10, Issue 2, 2007, Pages 173-184

  Lenk, Christian ^a   Biller Andorno, Nikola ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Civil liberties; Enhancement; Ethics; Identity; Nanomedicine; Nanotechnology; Risk assessment; Society

Indexed keywords

ARTICLE; EGO; ETHICS; HUMAN; MEDICAL TECHNOLOGY; NANOMEDICINE; PHILOSOPHY; RISK ASSESSMENT; RISK MANAGEMENT;

BIOMEDICAL TECHNOLOGY; EGO; HUMANS; NANOMEDICINE; PHILOSOPHY, MEDICAL; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 34250689133     PISSN: 13867423     EISSN: 15728633     Source Type: Journal    
DOI: 10.1007/s11019-006-9014-6     Document Type: Article

References (49)

1. Academy for Technology Assessment Baden-Württemberg (ed.): 2002, Quo vadis homine? Der neue Realismus in den Zukunftstechnologien - Tagungsbericht, Die Zukunft des Menschen: Gentechnologie, Nanotechnologie, Künstliche Intelligenz', www.z-punkt.de/download/ z-tagungsbericht0102.pdf
2. Allianz Group/OECD: 2005, Opportunities and Risks of Nanotechnologies. London & Ismaning
3. Anderson W.F. (1985) 'Human Gene Therapy: Scientific and Ethical Considerations'. The Journal of Medicine and Philosophy 10:275-291
4. Bayertz K. (1994) GenEthics: Technological Intervention in Human Reproduction as a Philosophical Problem. Cambridge University Press, Cambridge
5. Bharali D.J., Klejbor I., Stachowiak E.K., Dutta P., Roy I., Kaur N., Bergey E.J., Prasad P.N., Stachowiak M.K. (2005) 'Organically Modified Silica Nanoparticles: A Nonviral Vector for in vivo Gene Delivery and Expression in the Brain'. Proceedings of the National Academy of Sciences of the USA 102(32):11539-11544
6. Bianco A., Kostarelos K., Prato M. (2005) 'Applications of Carbon Nanotubes in Drug Delivery'. Current Opinion in Chemical Biology 9(6):674-679
7. Birnbacher D. (1991) Ethische Dimensionen bei der Bewertung technischer Risilken. In: Lenk H., Maring M. (eds.), Technikverantwortung. Güterabwägung, RisikobewerLung, Verhaltenskodizes, Campus Verlag, Frankfurt a.M., pp. 136-147
8. Böhnigk, V.: 2000, Article Risiko/Risikoanalyse/Risikoforschung'; Section 2, Philosophical', in: Lexikon der Bioethik, Gütersloher Verlagshaus, Gütersloh, pp. 210-216
9. Bostrom, N.: 2000, The World in 2050', www.nickbostrom.com/2050/ world.html; accessed Jan. 1st, 2006
10. British Royal Society/Royal Academy of Engineering: 2004, Nanoscience and Nanotechnologies: Opportunities and Uncertainties. London
11. Davis, K.: 1995, Reshaping the Female Body: The Dilemma of Cosmetic Surgery, New York
12. Decker M. (2003) 'Definitions of Nanotechnology - Who needs them?'. Newsletter of the European Academy Neuenahr-Ahrweiler 41:1-3
13. Drexler K.E. (1986) Engines of Creation: The Coming Era of Nanotechnology. Anchor Press/Doubleday, New York
14. Economic & Social Research Council (ESRC): 2003, The Social and Economic Challenges of Nanotechnology, WWW.esrc.ac.uk/esrccontent/ Download Docs/Nanotechnology. pdf
15. Emerich D.F. (2005) 'Nanornedicine - Prospective Therapeutic and Diagnostic Applications'. Expert Opinion on Biological Therapy 5(1):1-5
16. Ferber D. (2001) 'Gene Therapy: Safer and Virus-Free?'. Science 294:1638-1642
17. Freed C.R. (2002) 'Will Embryonic Stem Cells be a Useful Source of Dopamine Neurons for Transplant into Patients with Parkinson's Disease?'. Proceedings of the National Academy of Sciences of the United States of America 99:1755-1757 1755-1757
18. Freitas, R.A.: 1999, Nanomedicine, Vol.I: Basic Capabilities - Landes Biosciences, Georgetown, TX, www.foresight.org/Nanornedicine/
19. German Parliament's Office for Technology Assessment: 2003, Nanotechnologie, Working Report #92, Berlin
20. Gordijn B. (2005) 'Nanoethics: From Utopian Dreams and Apocalyptic Nightmares Towards a More Balanced View'. Science and Engineering Ethics 11(4):521-533
21. Habermas J. (2001) Die Zukunft der menschlichen Natur. Auf dem Weg zu einer liberalen Eugenik?. Suhrkainp, Frankfurt a.M.
22. Hoet, P.H.M., I. Brüske-Hohlfeld and O.V. Salata: 2004, 'Nanoparticles - Known and Unknown Health Risks', Journal of Nanobiotechnology, 2(12), www.jnanobiotechnology.com/content/2/1/12
23. Honnefelder, L. (1997) Medizinische Ethik and ärztliche Teleologie. Zu den ethischen Aspekten der Behandlung irreversibel bewusstloser Patienten. In: Honnefelder L., Streffer C. (eds.), Jahrbuch für Wissenschaft and Ethik, Vol. II. de Gruyter, Berlin and New York, pp. 169-180
24. Jordan A. (2001) Nanotechnologie - ein neues Konzept für Diagnostik und Therapie maligner Tumoren. Der Onkologe 10:1073-1081
25. Kalitzkus V. (2003) Leben durch den Tod. Die zwei Seiten der Organtransplantation. Eine medizinethnologische Studie. Campus Verlag, Frankfurt am Main
26. Kramer P.D. (1994) Listening to Prozac. Fourth Estate, London
27. Lehrman S. (1999) 'Virus treatment questioned after gene therapy death'. Nature 401:517-518
28. Lenk C. (2002a) Therapie and Enhancement. Ziele and Grenzen der modernen Medizin. Lit Verlag, Münster
29. Lenk C. (2002b) 'Health and Enhancement. In: Gimmler A., Lenk C., Aumüller G. (eds.), Health and Quality of Life'. Philosophical, Medical, and Cultural Aspects. Lit Verlag, Münster, pp. 37-46
30. Lenk H. (2002) Erfolg oder Fairness? Leistungssport zwischen Ethik and Technik. Lit Verlag, Münster
31. Manzei A. (2003) Kritische Anthropologie any Beispiel der Transplantationsmedizin. Lit Verlag, Münster
32. Mill, J.S.: 2003, On liberty. Haven, C. et al.: Yale University Press. First published in 1859
33. Mnyusiwalla A., Daar A.S., Singer P.A. (2003) 'Mind the Gap': Science and Ethics in Nanotechnology. Nanotechnology 14:R9-R13
34. Moghimi S.M., Hunter A.C., Murray J.C. (2005) 'Nanomedicine: Current Status and Future Prospects'. FASEB Journal 19(3):311-330
35. Montemagno C.D., Bachand G.D. (1999) 'Constructing Nanomechanical Devices Powered by Biomolecular Motors'. Nanotechnology 10:225-331
36. National Bioethics Advisory Commission (NBAC) (ed.): 1998, Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity', Volume I, Report and Recommendations of the National Bioethics Advisory Commission, Chapter IV, The Assessment of Risk and Potential Benefit', www.georgetown.edu/research/nrcbl/nbac/capacity/ Assessment.htm
37. National Science Foundation (NSF) (ed.) (2002) Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science. Arlington, Virginia
38. Nedbal D. (2001) 'Forever Young oder die ewige Jugend'. Bayerisches Ärzteblatt 12:650-651
39. Oberdörster E. (2004) Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass. Environmental Health Perspectives 112(10):1058-1062
40. Paschen H., Coenen C., Fleischer T., Grünwald R., Oertel D., Revermann C. (2003) Nanotechnologie, Endbericht. TAB-Arbeitsbericht 92, Berlin
41. Quante, M.: 2002, Personales Leben und menschlicher Tod. Personale Identität als Prinzip der biomedizinischen Ethik. Suhrkamp, Frankfurt a.M.
42. Salem A.K., Searson P.C., Leon K.W., (2003) 'Multifunctional Nanorods for Gene Delivery'. Nature Materials 2:668-671
43. Savulescu J. (2001) Harm, Ethics Committees and the Gene Therapy Death. Journal of Medical Ethics 27:148-150
44. Service R.F. (2003) 'Nanomaterials Shows Signs of Toxicity'. Science 300:243
45. Shrader-Frechette, K.: 1997, 'Technology and Ethical Issues', in: Shrader-Frechette, K.; Westra, L. (eds.), Technology and Values, Rowman & Littlefield Publishers, Lanham et al., pp. 25-31
46. Sloterdijk P. (1999) Regeln füs den Menschenpark Ein Antwortschreiben zu Heideggers Brief über den Humanismus. Suhrkamp, Frankfurt a.M.
47. SwissRe (ed.): 2003, Nanotechnology - Small matter, many unknowns, www.swissre.com.
48. U.S. National Science and Technology Council (1999) Nanotechnology - Shaping the World Atom by Atom. Washington, D.C.
49. Wehner-v. Segesser, S. 2002, Nanotechnologie in der Medizin. Zukunftshoffnungen für Diagnostik and Krebstherapie', Neue Zürcher Zeitung Online, 30-01-2002, www.nzz.ch/2002/01/30/ft/ page-article7XBGQ.html